Early Effect of 0.005% Estriol Vaginal Gel on Symptoms and Signs of Vulvovaginal Atrophy

OBJECTIVES: This study aims to assess the effect of ultralow dose 0.005% estriol vaginal gel in women with genitourinary syndrome of menopause (GSM). METHODS: In this prospective and multicenter single-arm study, efficacy was assessed by the evaluation of the epithelial maturation value (MV), vagina...

Descripción completa

Detalles Bibliográficos
Autores principales: Lázaro-Carrasco de la Fuente, Jesús, Cuerva González, Marcos, González Rodríguez, Silvia, Delgado Marín, Juan Luis, Cuevas Castillo, Carmen, Nieto Magro, Concepción
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Menopause 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452593/
https://www.ncbi.nlm.nih.gov/pubmed/36070871
http://dx.doi.org/10.6118/jmm.21038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452593/
https://www.ncbi.nlm.nih.gov/pubmed/36070871
http://dx.doi.org/10.6118/jmm.21038

Ejemplares similares